Chemoinformaics analysis of Methyl 3-methyl-2-butenoate
| Molecular Weight | 114.144 | nRot | 1 |
| Heavy Atom Molecular Weight | 104.064 | nRig | 2 |
| Exact Molecular Weight | 114.068 | nRing | 0 |
| Solubility: LogS | -1.297 | nHRing | 0 |
| Solubility: LogP | 1.609 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 18.2919 |
| nHD | 0 | BPOL | 12.6361 |
| QED | 0.377 |
| Synth | 2.256 |
| Natural Product Likeliness | 1.331 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.023 |
| HIA | 0.005 |
| CACO-2 | -4.204 |
| MDCK | 0.0000227 |
| BBB | 0.998 |
| PPB | 0.252894 |
| VDSS | 0.851 |
| FU | 0.765531 |
| CYP1A2-inh | 0.8 |
| CYP1A2-sub | 0.816 |
| CYP2c19-inh | 0.714 |
| CYP2c19-sub | 0.89 |
| CYP2c9-inh | 0.249 |
| CYP2c9-sub | 0.267 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.443 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.315 |
| CL | 9.208 |
| T12 | 0.855 |
| hERG | 0.008 |
| Ames | 0.008 |
| ROA | 0.035 |
| SkinSen | 0.923 |
| Carcinogencity | 0.182 |
| EI | 0.957 |
| Respiratory | 0.238 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.945276 |